Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Oct 11, 2026
TickeronGET DAILY SIGNALS
Marsh McLennan (MRSH) Q3 2026 Earnings Preview: What Analysts Are Watching

Marsh McLennan (MRSH) Q3 2026 Earnings Preview: What Analysts Are Watching

Key Takeaways

  • Marsh McLennan (MRSH) is scheduled to report third-quarter 2026 results on Thursday, October 15, 2026, before the market opens.
  • Analyst consensus points to earnings of roughly $1.96 per share, up about 6% from the prior-year quarter.
  • Consensus revenue is approximately $6.63 billion, an expected increase of about 4.5% year over year.
  • The company topped expectations in its most recent quarter, posting $2.96 per share versus a $2.88 estimate.
  • Investors will focus on organic growth, insurance pricing trends, and management's full-year guidance.

Why These Results Carry Weight

Marsh McLennan stands as one of the largest professional services firms globally, covering risk management, insurance broking, consulting, and workforce strategies. With clients spanning multinationals to mid-sized companies, its performance offers a useful window into corporate confidence and spending patterns. The firm has posted a consistent series of earnings beats, including the second quarter of 2026 when results came in above consensus. That history sets a high bar for the upcoming report, as investors seek signs that demand for risk advisory, insurance placement, and consulting services holds up amid economic uncertainty.

Consensus Estimates for the Quarter

Wall Street expects earnings per share of about $1.96 for the third quarter of 2026, representing a year-over-year rise of roughly 6%. Revenue is projected near $6.63 billion, up approximately 4.5% from the same period last year. These numbers reflect analyst estimates rather than company guidance and serve as a reference point.

In the previous quarter, MRSH reported EPS of $2.96 against a consensus of $2.88, with revenue climbing 6.2% year over year to $7.28 billion. Attention will turn to whether the company sustains that pace, especially within its Risk & Insurance Services segment, the larger and steadier contributor. Key areas to track include organic revenue growth, adjusted operating margins, and any updates on insurance pricing across property, casualty, and specialty lines. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

Market Sentiment Heading Into the Report

Investor views on MRSH reflect its profile as a defensive, cash-generative business with a reliable history of beating estimates. That consistency has tended to limit post-earnings volatility relative to more cyclical sectors, yet the market still responds to surprises in growth, margins, or outlook. Potential concerns include any easing in insurance pricing, softer consulting demand, or currency effects that could pressure reported revenue. Even a solid earnings beat paired with cautious commentary on the call could lead to a measured reaction, highlighting the importance of management’s tone.

Items to Monitor After the Release

Following the report, focus will shift to the company’s organic growth path, which removes acquisition and currency impacts to reveal underlying demand trends. Strength in Risk & Insurance Services would point to healthy client spending on coverage and advisory services, while any slowdown might signal pricing pressure or reduced renewals.

Margin trends deserve attention as well. As a professional services provider, profitability hinges on cost control and efficiency, so remarks on compensation expenses, technology spending, and operating leverage will inform the full-year outlook.

Updates to 2026 guidance and any notes on capital allocation, including buybacks or dividends, will also matter. Broader industry factors such as property and casualty pricing cycles and consulting demand will help shape how the results are interpreted for future quarters.

Using AI Tools for Deeper Analysis

In my own review process, Tickeron’s AI-powered screening capabilities have proven useful for quickly comparing MRSH against peers and spotting technical or fundamental shifts in the insurance and professional services space. The platform lets users apply filters across industries, market caps, patterns, and performance metrics to surface relevant ideas more efficiently than manual methods. From what I see, this approach helps keep the focus on the metrics that matter most ahead of events like earnings releases.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: MRSH

Contributor

Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.


MRSH's RSI Indicator recovers from overbought zone

The 10-day RSI Indicator for MRSH moved out of overbought territory on November 06, 2026. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 33 instances where the indicator moved out of the overbought zone. In 17 of the 33 cases the stock moved lower in the days that followed. This puts the odds of a move down at 52%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Moving Average Convergence Divergence Histogram (MACD) for MRSH turned negative on November 13, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 49 similar instances when the indicator turned negative. In 25 of the 49 cases the stock turned lower in the days that followed. This puts the odds of success at 51%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where MRSH declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 44%.

MRSH broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 36 of 57 cases where MRSH's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 63%.

The Momentum Indicator moved above the 0 level on November 20, 2026. You may want to consider a long position or call options on MRSH as a result. In 48 of 86 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 56%.

MRSH moved above its 50-day moving average on October 15, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for MRSH crossed bullishly above the 50-day moving average on October 20, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 7 of 21 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 33%.

Following a +2.04% 3-day Advance, the price is estimated to grow further. Considering data from situations where MRSH advanced for three days, in 164 of 340 cases, the price rose further within the following month. The odds of a continued upward trend are 48%.

The Aroon Indicator entered an Uptrend today. In 91 of 263 cases where MRSH Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 35%.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 31 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 37 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is 40 (best 1 - 100 worst), indicating steady price growth. MRSH’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 64 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 85, placing this stock slightly better than average.

The Tickeron Valuation Rating of 90 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.438) is normal, around the industry mean (2.794). P/E Ratio (24.948) is within average values for comparable stocks, (19.877). Projected Growth (PEG Ratio) (1.486) is also within normal values, averaging (8.322). Dividend Yield (0.019) settles around the average of (0.042) among similar stocks. P/S Ratio (3.089) is also within normal values, averaging (3.106).

Notable companies

The most notable companies in this group are eHealth (NASDAQ:EHTH).

Industry description

Insurance brokers sell, solicit, or negotiate insurance for compensation. General insurance brokers mostly cater to insurances on car, house etc. (versus life). Brokers are also often instrumental in helping small employers find health insurance, particularly in more competitive markets. Additionally, brokers may also provide risk assessments, insurance consulting services, insurance-related regulatory and legislative update services. Some of the major names in this industry include Marsh & McLennan Companies, Inc., Aon plc and Verisk Analytics Inc.

Market Cap

The average market capitalization across the Insurance Brokers/Services Industry is 16B. The market cap for tickers in the group ranges from 3.03K to 97.74B. MRSH holds the highest valuation in this group at 97.74B. The lowest valued company is CUII at 3.03K.

High and low price notable news

The average weekly price growth across all stocks in the Insurance Brokers/Services Industry was -9%. For the same Industry, the average monthly price growth was -6%, and the average quarterly price growth was 17%. CRVL experienced the highest price growth at 3%, while ZBAO experienced the biggest fall at -66%.

Volume

The average weekly volume growth across all stocks in the Insurance Brokers/Services Industry was -73%. For the same stocks of the Industry, the average monthly volume growth was 7% and the average quarterly volume growth was -5%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 59
P/E Growth Rating: 74
Price Growth Rating: 51
SMR Rating: 70
Profit Risk Rating: 84
Seasonality Score: 8 (-100 ... +100)
AI Patterns 1
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry InsuranceBrokersServices

Industry
N/A
Address
1166 Avenue of the Americas
Phone
+1 212 345-5000
Employees
95000
Web
https://www.corporate.marsh.com
Interact to see
Advertisement
The ADR gapped lower in premarket trading and was at $335.71 in early regular-session trading, -4.65% from Thursday's close of $352.09. The move extends a global AI and chip unwind: investors are cutting crowded semiconductor bets on stretched valuations, rising sector debt, data-center opposition and Nvidia's leadership turmoil, and Nvidia's strong quarter failed to calm sentiment.
Micron shares slid from Thursday's $690.44 close to $635.41, a -7.97% loss, deepening during Friday's regular session after an already soft premarket. The decline was sector-driven, not company-specific: investors kept unwinding AI exposure as Anthropic fell back after its debut, while hawkish Fed comments and doubts about Nvidia's leadership and AI spending returns pressured chip valuations.
Meta Platforms fell from a $596.22 previous close to $583.40, a -2.15% move, with the decline built in premarket trading and held through early Friday action after Thursday's -3.27% drop. The drop was sector-driven, not company-specific: Anthropic slid roughly -6% to -10% premarket on its second trading day, reviving doubts that AI spending will generate returns, and AI-linked megacaps sold off broadly with Nasdaq 100 futures down about -1.5%.
ANT dropped from Thursday's record-debut close of $97.17 to about $88.56 in Friday premarket trading, a -8.86% move ahead of the opening bell, still above its $83 IPO price. The decline came from a broad AI and technology selloff rather than any Anthropic-specific disclosure: Nvidia and AMD traded lower premarket, index futures were sharply down, and renewed doubts over AI spending and valuations drove profit-taking after the +17.07% first-day gain.
IREN dropped -8.33% to $13.21 from Thursday's $14.41 close, with weakness building in premarket and extending through the first hour of regular trading. The decline extends a sector-wide neocloud rout: Anthropic's post-IPO slide and turmoil at Nvidia revived doubts about debt-funded AI data center spending, dragging CoreWeave and Nebius down with it; no IREN-specific news was released.